By proceeding, you agree to our Terms of Use and Privacy Policy.
Oren Gilad is currently working as CEO at Atrin Pharmaceuticals.
Talks About #biotechnology #cell
Preferred Locations #Northamerica
The 5th Annual PARP, ATR & DDR Inhibitors Summit is the one-of-a-kind industry-focused summit dedicated to bringing new and novel next-generation DDR therapeutics to the clinic and finding optimal treatment combinations to expand application in multiple cancer indications.
The 6th DDR Inhibitors Summit 2023 is the premier event for pharmaceutical and biotech researchers to discuss advances, challenges, and new solutions in the field of DDR inhibitors.